AMGN
AMGN
$69.05
*
0.05
negative
0.07%

*Data as of May 25, 2012   | Amgen Inc. | Industry: Health Care | HQ: California, United States
 
 

Symbol List ViewsSymbol List Views

Stock DetailsStock Details

Stock DetailsCHARTS

Stock DetailsCOMPANY NEWS

Stock DetailsSTOCK ANALYSIS

Stock DetailsFUNDAMENTALS

Stock DetailsHOLDINGS

 Save stocks for next time
 |  Sponsored

AMGN News Headlines

Share |


   


Amgen Announces Voting Results Of Stockholders Meeting; CEO Kevin Sharer Retires
5/23/2012 5:20:00 PM - RTT News

Did You Buy These Stocks?
5/23/2012 8:50:00 AM - RTT News

Will Anthera's PEARL Shine Or Sink?
5/19/2012 5:37:00 AM - RTT News

Amgen Presents Oncology Data - Analyst Blog
5/17/2012 5:30:01 PM - Zacks.com

Merck KGaA's Erbitux Faces Hurdle - Analyst Blog
5/17/2012 1:38:58 PM - Zacks.com

Amgen: AMG 103 Phase 2 Data Shows High CR Rate In Leukemia Patients
5/16/2012 11:38:00 PM - RTT News

Amgen Reports Results On Exploratory Biomarker Analysis For AMG 102 Response
5/16/2012 6:42:00 PM - RTT News

Amgen Says BiTE Antibody Blinatumomab Achieved High Rate Of Complete Response
5/16/2012 6:34:00 PM - RTT News

Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars
5/11/2012 1:14:00 PM - RTT News

Ex-Dividend Stocks: Target, ConEd
5/11/2012 7:07:00 AM - TheStreet

UPDATE: Companies Pour Into High-Grade Corporate Bond Market
5/10/2012 6:28:00 PM - Dow Jones Business News

Amgen Sells $3 Billion In US Bond Market
5/10/2012 5:26:00 PM - Dow Jones Business News

Amgen To Present At Baird's Growth Stock Conference; Webcast At 9:20 AM ET
5/9/2012 8:20:00 AM - RTT News

Amgen To Present At Deutsche Bank Conference; Webcast At 9:20 AM ET
5/8/2012 8:20:00 AM - RTT News

House Panel Seeks Information From Drug Cos. On Health Law Agreements With White House -Bloomberg
5/4/2012 12:20:00 PM - Dow Jones Business News

3rd UPDATE: Pfizer Profit Falls 19% As Generics Hurt Lipitor Sales
5/1/2012 1:16:00 PM - Dow Jones Business News

2nd UPDATE: Pfizer Profit Falls 19% As Generics Hurt Lipitor Sales
5/1/2012 11:50:00 AM - Dow Jones Business News

CORRECT: UPDATE: Pfizer Profit Falls 19% As Generics Hurt Lipitor Sales
5/1/2012 11:47:00 AM - Dow Jones Business News

WSJ BLOG/Health: A.M. Vitals: U.S. Officials Defend Testing Regime for Mad Cow Disease
4/27/2012 9:14:00 AM - Dow Jones Business News

FDA Turns Down Expanded Use Of Amgen's Xgeva
4/27/2012 8:29:00 AM - RTT News

Amgen: FDA Letter Rejects Expanded Use Of Xgeva For Prostate Cancer
4/27/2012 7:21:00 AM - Dow Jones Business News

Wall Street On Tenterhooks As Economic Worries Linger
4/27/2012 6:52:00 AM - RTT News

Amgen Beats but Maintains Outlook - Analyst Blog
4/25/2012 9:50:36 AM - Zacks.com

Wall Street Savors Earnings Ahead Of FOMC Decision
4/25/2012 6:45:00 AM - RTT News

Amgen Agrees To Buy 95.6% Of Turkey's Mustafa Nevzat Pharma - Update
4/25/2012 3:17:00 AM - RTT News